logo
Aging in Place: How seniors are living safely in their homes for longer

Aging in Place: How seniors are living safely in their homes for longer

Yahoo2 days ago

More than a quarter of U.S. households are headed by someone 65 or older, a number that keeps growing; 77% of Americans over 50 want to remain in their homes as they age, according to AARP.
What demographers call the Silver Tsunami presents a growing need for modifications that let people live safely in the comfort of their houses for longer. Across New Jersey, a number of companies have come up with ways to help them do just that.
"I think it's absolutely critical to have seniors stay comfortable in their home as long as possible, because the data shows that there are better health outcomes," said Liz Rabban, co-owner of TruBlue Home Service Ally, based in Morristown and Montclair, New Jersey.
"And so for all of the reasons you would imagine why somebody wants to stay in their home, I think that building the support system for them to stay where they are is important," Rabban said.
For these services, she said, it's not just about finding somebody who will perform the necessary renovations; homeowners need someone who will put in the effort to truly understand each person's needs.
The sentiment was echoed by Linda Pollock, owner of North Jersey Maintenance Group, who said it's important to find a company with adequate training to handle these projects.
"There are companies out there that say they do Aging in Place services but don't have the training to really understand what seniors and individuals with disabilities really need," she said. "My goal is not to get rich on any individual client. I don't charge very much for my services because I want people to be safe and it's a true passion of mine."
In general, Pollock said, it's best to prepare your home for aging in place before you get into an accident or urgently need modifications.
Saverio Nestico is the president of Philadelphia-based SPN Cos., which does home modifications including bathrooms, kitchens, ramps and lifts for stairs and wheelchairs. The business helps clients across New Jersey, Pennsylvania and Delaware.
The first step typically involves an assessment by an occupational therapist, Nestico said. Often, it's prompted by a medical event that necessitates accommodations. The therapist will recommend ways to make a home safer and more accessible.
"The occupational therapist will go to the home and identify what's needed for the individuals," Nestico said. "We then take those recommendations and go out there, assess the home, take photos, measurements, speak to the individuals, understand what they're needing to accomplish.'
Both Rabban and Pollock said that before doing anything, they always complete home assessments to get a true feeling for what residents may be struggling with. They watch individuals go up stairs, see how they navigate bathrooms and observe how they get to things that are otherwise out of their reach. From there, they'll move on to making the necessary modifications.
Debbie and Charles Gibbs have begun the process. They moved to Lawrence Township to be closer to their daughter and son-in-law about a year ago. They appreciated the area's proximity to high-quality medical care and the international character of nearby Princeton.
But living comfortably in their Colonial, which has two floors and a basement, required some extra work. The couple recently had an elevator installed. Debbie, 71, said it was a proactive move.
"I have rheumatoid arthritis, and stairs are hard. We knew eventually I'd need it," she said. "I've never lived dependent on others, so the elevator gives me independence."
Now the former educator and current mixed media artist won't have to rely on her husband "to carry laundry or heavy things." That includes the tree branches, sticks, canvases and other assorted materials that she uses in her creations that line the walls of the house.
Finding the right company to install the elevator was crucial, Debbie said. "I didn't want to hire a contractor to do one part and then find someone else to do another," she said. After researching online, Gibbs found Mobility 123, a Garden State company that advertises comprehensive solutions and "turnkey" operations, handling everything from permits to construction.
Leon Fischer founded Lakewood-based Accessible Homes after noticing that many people who left hospitals and care facilities needed modifications to return home safely. His mission is to make homes more accessible and 'senior-friendly,' he said.
Falls are a leading cause of injury for seniors, says the National Institute on Aging. That's why Fischer advises people to secure rugs with nonslip pads and to ensure that paths are clear of clutter as first steps in making homes accessible.
Adding handrails and grab bars in critical areas such as bathrooms, along staircases and in hallways would be next in reducing fall risks, Fischer said. Lighting is another quick and easy enhancement that is often overlooked, he added: Motion-sensor lights for hallways, staircases and entrances can go a long way toward mitigating accidents in the home.
A final note from the experts when it comes to falls: Wearable smart devices can monitor heart rates and sleep patterns and detect falls. They can also alert emergency services if necessary, advises AARP. Devices like Google Home or Amazon Echo allow seniors to control lights with voice commands, They can also lock doors and operate televisions.
Both Pollock and Rabban said their services are broken into two categories: maintenance and modifications.
"When it comes to maintenance, you don't think of that as senior safety," Rabban said. "But when you think of seniors having to get up on a ladder to change their smoke detector batteries and things like that, it is."
Each of their companies offers programs in which they will come to their clients' homes four times a year, or as needed, and perform routine maintenance. That involves things like changing old filters and batteries in smoke detectors, among other tasks.
Common remedies include grab bars and railings, improved lighting and nonslip flooring, as well as switching out bathtubs for walk-in showers and widening doorways to make them more accessible. But there are a variety of other modifications that can be made for those looking to age in place, depending on needs.
"When I say 'senior,' there's a very big spectrum. There's a really big difference between somebody who's 65 and somebody who's 85. so the needs for people are different," Rabban said.
In some instances, Pollock has also added lockboxes to properties so that if the homeowner does fall or have some other accident, and they don't have family nearby, first responders can easily gain access to the home. Similarly, she has installed baby cameras so live-in help or relatives can keep track of seniors as they move around their home for further peace of mind.
"If they have the choice of being able to stay in their home or going to assisted living, there are pros and cons to both. But overall, I think seniors want to stay at home because they're comfortable where they are," Pollock said. "Seniors should be able to stay in their home if that's what they choose, so having services available that help make their spaces safe is important."
Costs and timing vary significantly.
Simpler installations like grab bars range from $100 to $200. In terms of timelines, the most basic jobs like adding aluminum ramps, widening a doorway for a wheelchair or installing bars and a nonslip floor in a shower can be done in a day.
Nestico said transforming a bathroom to be fully accessible might involve "redoing the surroundings to accommodate a roll-in shower or a walk-in tub, which can cost upwards of $10,000 to $12,000." The job typically takes two to three weeks to complete depending on the extent of the modifications and the need for custom solutions.
Home elevators are among the most complex modifications, often requiring extensive planning, structural changes and lengthy time frames.
"Comprehensive projects like installing an elevator start around $35,000, including all necessary construction and permits, and can take several weeks to months, depending on the complexity and the specific requirements of the building codes,' said Ryan Penn, owner of Mobility 123.
Mobility 123 grew out of Penn's father's durable medical equipment company, Diamond Scooters, which sold scooters and wheelchairs in the early 2000s. The business now focuses on more extensive modifications like elevators. The company operates from three locations, in Absecon, Tuckerton and Hillsborough, and serves New Jersey, parts of Connecticut, and Philadelphia.
The cost of Debbie and Charles Gibbs' three-stop elevator exceeded $60,000 due to additional construction and enclosing the elevator shaft, said Charles, 74.
He emphasized the need to plan ahead financially: "We thought it was smart to do this while I'm still earning some money, rather than waiting until later."
Accessibility modifications often can be partly financed through tax incentives, Medicaid programs, private insurance and veterans' benefits, said Tom Beck of Mobility 123, who also highlighted specific state resources.
"In New Jersey, Medicaid typically covers about $5,000 for something like a stair lift and recently increased coverage to about $15,000 for prescribed needs," he said. The Department of Veterans Affairs "also offers grants for veterans, even if disabilities are not service-related."
The Internal Revenue Service allows deductions for modifications deemed medically necessary. Eligible projects include widening doorways and hallways, installing ramps, adding grab bars, lowering countertops and adding stair lifts. To qualify, modifications must address a medical condition. Only expenses exceeding 7.5% of adjusted gross income are deductible, says Lifeway Mobility, a home accessibility company.
Medicaid coverage varies by state. In New Jersey, some home modifications can be covered under the Managed Long Term Services and Supports program, says the state's Department of Human Services.
Private health insurance coverage for such work differs significantly among policies. But some may cover prescribed modifications, so Penn suggests exploring both insurance and state aid programs.
Traditional Medicare typically doesn't cover home modifications, its website says. However, some seniors with prescriptions may get limited coverage for enhancements like wheelchair ramps or walk-in tubs, says The Senior List, an online resource for older adults.
Veterans with disabilities may also be eligible for grants through several programs, including the Specially Adapted Housing Grant for extensive home renovations and the Home Improvements and Structural Alterations Grant, which covers medically necessary projects like ramps and bigger doorways, says Rosarium Health, an accessibility company.
Debbie Gibbs encouraged homeowners to start the process early.
"From looking into an elevator to having it installed took about six months, mostly due to permitting and ordering," she said. "Planning ahead made it manageable."
This article originally appeared on NorthJersey.com: Home renovation tips for seniors looking to stay in family homes

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trump to celebrate 'partnership' between US Steel and Nippon Steel, a merger he once opposed
Trump to celebrate 'partnership' between US Steel and Nippon Steel, a merger he once opposed

Yahoo

time13 minutes ago

  • Yahoo

Trump to celebrate 'partnership' between US Steel and Nippon Steel, a merger he once opposed

President Donald Trump on Friday visits Pittsburgh to celebrate what he says is a "planned partnership" between U.S. Steel and the Japanese company Nippon Steel, after previously opposing a merger. Trump is set to deliver remarks at 5 p.m. ET about the "U.S. Steel Deal" at a rally at the Irvin Works in Allegheny County, according to the White House. Trump announced the agreement on his conservative social media platform last week. He said it will create at least 70,000 jobs and add $14 billion to the American economy. The "investment," he wrote, would take place over the next 14 months and keep U.S. Steel headquartered in Pennsylvania. Trump, during the 2024 campaign, pledged to block the Japanese steelmaker from purchasing U.S. Steel. As president-elect, he repeated that vow. "I am totally against the once great and powerful U.S. Steel being bought by a foreign company, in this case Nippon Steel of Japan," Trump wrote in a post to his conservative social media platform in early December. The Biden administration in January blocked the sale of U.S. Steel to Nippon Steel over national security concerns. The White House said at the time it was important to keep one of the largest steel producers in the nation an American-owned company. MORE: Biden blocks US Steel takeover by Japan-based Nippon The reaction was mixed. The president of the United Steelworkers union, which represents hundreds of thousands of workers, celebrated the move while local leaders expressed concern about U.S. Steel's future in southwestern Pennsylvania. Weeks after the inauguration, Trump met with U.S. Steel CEO David Burritt at the White House. In early April, he ordered a new national security review of Nippon Steel's proposed bid to acquire U.S. Steel. The White House has provided few details, other than those mentioned by Trump in his social media post, about the agreement. Peter Navarro, Trump's trade adviser, insisted on Thursday that U.S. Steel "owns" the company. "Nippon Steel is going to have some involvement but no control of the company," Navarro told reporters outside the White House, though he didn't take any more questions on the agreement. Nippon was seeking 100% ownership of U.S. Steel in talks with Trump, Nikkei Asia reported earlier this month. U.S. Steel issued a brief statement last week in which it said Trump "is a bold leader and businessman who knows how to get the best deal for America." "U. S. Steel will remain American, and we will grow bigger and stronger through a partnership with Nippon Steel that brings massive investment, new technologies and thousands of jobs over the next four years," the company said without sharing more specifics. Trump to celebrate 'partnership' between US Steel and Nippon Steel, a merger he once opposed originally appeared on

A potential new treatment for Parkinson's shows early promise
A potential new treatment for Parkinson's shows early promise

USA Today

time13 minutes ago

  • USA Today

A potential new treatment for Parkinson's shows early promise

A potential new treatment for Parkinson's shows early promise | The Excerpt On a special episode (first released on May 29, 2025) of The Excerpt podcast: Parkinson's is a disease that afflicts an estimated 90,000 Americans every year. Dr. Lorenz Studer and Dr. Viviane Tabar of Memorial Sloan Kettering Cancer Center, joined USA TODAY The Excerpt to share more about a new stem cell-based therapy that creates nerve cells. The treatment is showing early promise. Hit play on the player below to hear the podcast and follow along with the transcript beneath it. This transcript was automatically generated, and then edited for clarity in its current form. There may be some differences between the audio and the text. Podcasts: True crime, in-depth interviews and more USA TODAY podcasts right here Karen Weintraub: Hello, and welcome to The Excerpt. I'm USA TODAY Health Reporter Karen Weintraub. Today is Thursday, May 29th, and this is a special episode of The Excerpt. You've no doubt heard of the chemical dopamine. It's often referenced as part of the brain's reward system when we do something pleasurable. Dopamine, or a lack thereof, also plays a critical role in the onset of Parkinson's, a disease that afflicts an estimated 90,000 Americans every year. Treatment for Parkinson's focuses on managing its many symptoms, as there is no cure. But a new stem cell therapy developed at Memorial Sloan Kettering Cancer Center for advanced Parkinson's is showing early promise. What's behind this incredible discovery and just how hopeful should patients be? Here to talk about this exciting new treatment and its impact on patients are the two physicians who helped make it a reality. Dr. Viviane Tabar and Dr. Lorenz Studer. Drs. Tabar and Studer, thanks so much for joining The Excerpt. Dr. Tabar, when someone is diagnosed with Parkinson's disease, what exactly is happening to their brain and their body? Dr. Viviane Tabar: Well, we think that at the time an individual is diagnosed with Parkinson's disease, they have already experienced degeneration or loss of a large number of their dopamine neurons. We are all born with a limited number of large, beautiful dopamine neurons that live in our brainstem and that project to multiple areas in the brain. They're involved in a lot of intricate activities, but an important element of their function is to modulate movement. So the individual very commonly will come to clinical attention because of movement difficulties, albeit there are other symptoms, loss of smell, gastrointestinal symptoms, difficulties with sleep, and it's a complex picture. But it's important to remember that at the time they receive this diagnosis, which today is still vastly made on a clinical basis, on an examination of the individual and listening to their symptoms, they have already lost probably 50% or more of their dopamine neurons and their projections. A potential new treatment for Parkinson's shows early promise A new stem cell-based therapy creates cells that make dopamine, a chemical that's critical to the disease. Karen Weintraub: And what are some of the everyday challenges your patients face? You mentioned motor control, cognitive issues also I think? Dr. Viviane Tabar: For the majority of patients, and keep in mind that Parkinson's is a disease that spans a variety of symptoms and spectrum of progression and intensity, for most patients it starts with manageable symptoms that they control well, could be a tremor, could be some stiffness in their gait. And for the majority, I would say cognitive change comes late, assuming a proper diagnosis of Parkinson's. So it becomes paradoxically even more problematic because it starts interfering with activities of daily living, your ability to get to and from your job. You're still high-performing, but you are impaired gradually. And you're fully cognitively there often, and so you're very aware of the slow degeneration that's essentially relentless. Karen Weintraub: And you mentioned jobs. Are people affected by Parkinson's primarily older, retiree age, or are there other groups at risk as well? Dr. Viviane Tabar: We didn't say necessarily retirees. Parkinson's, the sporadic form of it, which is the most common form, I mean by that the form that's not inherited, that happens commonly in the sixties or later. But nowadays, people in their fifties and sixties are considered at their prime still at work. Karen Weintraub: And others who are affected, we think of Michael J. Fox who is certainly younger when he started developing symptoms. Dr. Viviane Tabar: There are forms of Parkinson's that occur in a younger individual at a younger average age, and that is commonly related to specific mutations. And so the majority of Parkinson's disease occurs what we call sporadically, so without a hereditary or identified specific mutation that we are aware of. But some is related to a mutation, and those tend to occur at a younger age, but that's not the majority. Karen Weintraub: And is it clear what causes Parkinson's? You mentioned the neurons, but is there still some mystery there, and can the causes vary from person to person? Dr. Viviane Tabar: There is a lot of mystery. So in simple terms, we do not know the etiology of Parkinson's disease very specifically. Many things have been invoked, the environment, environmental toxins, a genetic predisposition outside of the genetic forms of the disease. And we can talk a lot about some exciting science trying to dissect what's going on, the role of inflammation, et cetera. But the short answer to your question is we're not able today to tell a patient what caused their Parkinson's, again, outside the relatively uncommon hereditary forms. Karen Weintraub: And can you walk us a little bit through how Parkinson's progresses over time? Is there a sort of a path, many paths, what does that look like? Dr. Viviane Tabar: So yes, there are many paths, but let's take an average situation. The patient would reach out to a physician, eventually come to the attention of a neurologist, they're examined, their brain scan is obtained. In the case of Parkinson's, often that scan is fine and normal to age and the symptoms are identified often, as we said earlier, motor symptoms. The common situation is that they get started on a form of dopamine that can reach the brain, and that makes them feel better and that is often referred to as the honeymoon period. And that goes on for a few years where the patient is almost back to normal but dependent on the medicine. And as time goes by, the disease process is such that they are losing more and more of their dopamine neurons. And at some point we start or the treating neurologist starts escalating the dose of the medication. And there are other medications that can support that. But essentially within a few years or several years depending, they reach a point where they're starting to experience side effects from the medication and a shortening of the periods where they are feeling okay and functioning. And that is where we start getting stuck in that there are no new medications that, I shouldn't say no new medications, there's always new medications, no formulations that try to extend the ability to help the individual. But you clearly plateau in terms of the effectiveness of pharmacological therapy for a lot of patients, not all. There are options that are surgical like inserting electrodes that is called deep brain stimulation, which will work for some patients. But we reach a point where the patient has lost most of their dopaminergic neurons and there is not much more that can be offered today to help the individual. Hence, the idea of what if we could replace those degenerated dopamine neurons? Karen Weintraub: Which brings us to Dr. Studer. Dr. Studer, when did you first think about using stem cells as a possible way to treat Parkinson's? Dr. Lorenz Studer: Well, it's really a very long story. In fact, it's I think nearly three decades when we first had the idea of doing so, which was the question, "Now, can we really replace cells in the brain and what will be the right source?" In fact, that was the goal of my laboratory starting 25 years ago, finding exactly what's the source of dopamine neurons. The challenge is how do you make this very, very specific nerve cell in the brain? And so that was a long journey, took us at least 10 years of basic research to understand, now what is the code of development? It's a little bit like trying to go through the steps that the cells go in normal development, but give them those signals one by one in a culture dish. And so it's a little bit like a code that we need to decipher and then to apply to the cells. And by 2011, we could do that finally in a study that showed that we did a good job because when we implant those cells back into a mouse, in a rat or in a monkey model of Parkinson's disease, we see benefit in that model. And that really then opened up the whole next new step, now can we do that not just in a animal model, but maybe eventually in humans? That was what they call the proof of concept. But then obviously it was not a long journey to get to the ultimate clinical patient. Karen Weintraub: And how might the stem cell therapies transform the treatment landscape? What opportunities does this offer? And are there specific symptoms that you expect to get better or everything or certain symptoms? Dr. Lorenz Studer: The dopamine acts primarily on the movement-related symptoms. That's the area where we think we can make the biggest impact. Whether it's also going to affect all the symptoms, it's more questionable. Now, for example, again, we said the patients can have loss of smell, they can have problems with severe constipation, and at later stage of the disease, cognitive issues. And at this point we don't have a good reason to believe that this therapy will also help with those symptoms. This has to be tested. It could be indirect effects, but the main effect we expect is that the movement disorder should improve. Again, we don't want to overstate it, but in a dream scenario, it would be you have still Parkinson's disease, so you cannot cure Parkinson's disease, but maybe if it worked, ideally you could cure the movement disorder component of Parkinson's disease. And so I think that's really what we are trying to develop with this type of cell therapy. And maybe in the future this will open up the same approach for all the cell types that might affect all the symptoms as well. So it's also kind of opening up the door to many other cell therapies in Parkinson's itself and maybe in other diseases as well, because it's one of the first cases now where really you actually replacing nerve cells in the brain, which sounds like a little bit of a science fiction approach. But I think this is one of the first examples where we really tried to attempt that and hopefully opening the door now for applications in the future. Karen Weintraub: And you said we can't call this a cure, obviously it's early days, but what would it take to get to a cure? More cell types? Dr. Lorenz Studer: Yeah. I think, because again, Parkinson's has more than just a movement disorder. So all that's not just movement-related, there is late stages cognitive problems, gastrointestinal problems, sleep problems, and those are unlikely to be treated with this cell type. So what you can envisage is yes, well, maybe you would have additional cell types that can attack that, or ideally, you brought that up now, what causes Parkinson's disease, it'll be a complementary approach where you would give the cells back, because many dopamine cells are already lost by the time you're diagnosed. So you get that movement-related symptoms hopefully restored, but at the same time, you'll find, like the whole field, many thousands researchers try to do that, find a therapy that can slow down or stop the progression. So you would gain back the function that you've already lost, but you would maybe not get some of those later symptoms. That would be even bigger dream in the future. Karen Weintraub: I was going to ask, Dr. Studer, where the research goes from here? Dr. Lorenz Studer: We always talk about bench to bedside, but there's also a bedside to bench. So where you kind of try to figure out, so what could you do even better now with regard to the cells that they function maybe more quickly or they are more potent or they have some additional features like we discussed? How could it treat some of the other symptoms in the future? So I think that's a big area for Parkinson's disease itself. How can we get the most benefit out of this kind of an approach? But then the other part is really there's so many other very severe diseases now. We talk about Alzheimer's disease, we talk about ELS and other disorders. Each of them might need a different approach, quite different. So in some case we don't think we can just replace nerve cells, but we still learn that maybe other approaches could be used in those specific disorders. And it then gives us a lot of encouragement when we see some progress in one area that this might be not just kind of a one-time go, but we might have opportunities to now give some help to those very difficult to treat neurodegenerative disorders where even today, this has been kind of some of the value of this for many of the drugs. Now, very, very few new drugs came up in the context of neurodegenerative disorders, and I don't think cell therapy is alone going to solve all of that, but it's yet the new tool that is becoming actually clinically a realistic option to replace cells, and I think that's quite exciting. There's some examples, for example, for treating eye disorders, so-called people who get blindness, macular degeneration, where data look quite promising. There's some examples maybe in very severe seizures where [inaudible 00:12:35] could be useful. So I think this is one of the very, very first example now where we now go all the way to this phase three study, but in the lab now we are thinking, "What did we learn? Why did it take us 25 years, for example? How can you make it quicker and what would be some of the next targets?" Because from the stem cell side, we learned a lot. So by now we can pretty much make any cell type of the brain. So that's a language to make this as no longer limiting. What's limiting is now to know what's really needed in each individual patient, which is going to be quite distinct and will take, again, a couple of years, but pretty confident not another 25-year step. Karen Weintraub: Well, we will stay tuned for that very exciting work. Thank you both so much for being on The Excerpt. Dr. Lorenz Studer: Thanks so much. Dr. Viviane Tabar: Thank you for having us. Karen Weintraub: Thanks to our senior producers, Shannon Rae Green and Kaely Monahan, for their production assistance. Our executive producer is Laura Beatty. Let us know what you think of this episode by sending a note to podcasts@ Thanks for listening. I'm USA TODAY Health Reporter Karen Weintraub. Taylor Wilson will be back tomorrow morning with another episode of The Excerpt.

Why Cyber Specialists Thrive During Economic Downturns
Why Cyber Specialists Thrive During Economic Downturns

Associated Press

time19 minutes ago

  • Associated Press

Why Cyber Specialists Thrive During Economic Downturns

Cary, NC, May 30, 2025 (GLOBE NEWSWIRE) -- While tech giants have eliminated 300,000+ jobs over two years, cybersecurity professionals face a different reality. Organizations desperately need cybersecurity talent, yet many positions remain unfilled -- not from lack of demand, but because employers won't settle for candidates without specialized skills. This creates a unique opportunity: professionals who invest in targeted cybersecurity education and security certifications can build recession-proof careers while others struggle. INE Security, a leading provider of cybersecurity training and certifications, analyzed this market dynamic and found that specialization doesn't just improve job prospects, it multiplies career value exponentially. 'Specialization in cybersecurity creates a career insurance policy that generalists simply can't match,' explains Dara Warn, CEO of INE Security. 'While general IT professionals compete on price and availability, specialists compete on unique value. When you're one of the few professionals in your region who can architect zero-trust implementations or perform advanced mobile pentesting, you're not just employed – you're essential.' The Math That Matters: Why Specialization Pays The U.S. Bureau of Labor Statistics projects 33% growth for information security analysts through 2033, which is ten times faster than the average occupation. But despite 87% of companies reporting cybersecurity skill gaps (McKinsey & Company), many are willing to wait for the right candidates rather than hire generalists. This creates a mathematical advantage for specialists. When hundreds apply for general IT roles, specialized positions like mobile security pentester or cloud architect often struggle to find even five qualified candidates. That scarcity translates directly into negotiating power and compensation opportunities. The $4.88 Million Question With the average cybersecurity breach spiking 10% over the last year to $4.88 million (IBM Ponemon Institute), organizations can't afford mediocre security. They need specialists who can prevent, detect, and respond to threats immediately. Since 68% of breaches involve human elements like social engineering, according to Verizon's 2024 Data Breach Investigations Report, employers seek professionals who understand both technical vulnerabilities and human behavior patterns. This urgency explains why 91% of hiring managers prefer certified candidates (Fortinet) and why specialized roles command premium rates: The Certification Advantage: Real Numbers Professional certifications create measurable career advantages beyond just knowledge validation. Gallup research shows 81% of Americans with professional certifications are employed versus 68% without them. In cybersecurity, this advantage amplifies because security certifications prove competency in high-stakes scenarios. From foundational credentials like Sec+ to advanced pentester certifications, the progression path is clear. Career advancement opportunities expand dramatically with specialized certifications. This motivation helps combat feelings of career stagnation that contribute to burnout, an increasingly critical problem within the cybersecurity industry. But certifications alone aren't enough—employers increasingly demand proven practical experience. Beyond Paper: Why Hands-On Training Multiplies Value The business case is compelling: well-trained cybersecurity teams generate $70,000 in annual savings and 10% productivity increases (IBM). Organizations recognize this ROI, which explains why 67% prefer team members with certifications - they validate both knowledge and practical capability (Fortinet). Modern cybersecurity education leverages cyber ranges and virtual labs that simulate real attack scenarios. This allows professionals to practice incident response, penetration testing, and threat analysis without risking production systems. The result? Professionals who can demonstrate actual competency rather than just theoretical knowledge. Real-World Application: The eMAPT Example INE Security's enhanced Mobile Application Penetration Tester (eMAPT) certification exemplifies this integrated approach. Beyond advanced mobile security methodologies, the program includes extensive hands-on exercises in dedicated cyber ranges that replicate real mobile application infrastructures. Through June 24, 2025, learners can save $200 on the eMAPT certification and gain access to INE Security's updated Mobile Application Penetration Testing Learning Path. Learners practice iOS and Android security assessment against actual vulnerabilities in controlled environments. This combination of security certifications and practical lab experience addresses the core employer demand: verifiable expertise backed by demonstrated capability. The Ultimate Career Insurance Policy The cybersecurity profession rewards those who invest in continuous learning through specialized training. The combination of recognized security certifications, hands-on laboratory experience, and practical skill application creates professionals who thrive regardless of economic conditions. While traditional IT training paths may offer broader options, cybersecurity education provides something more valuable: career resilience in an increasingly uncertain world. As threats evolve and breach costs climb, organizations will continue prioritizing specialists who can deliver immediate value. About INE Security: INE Security is the premier provider of online networking and cybersecurity training and cybersecurity certifications. Harnessing a powerful hands-on lab platform, cutting-edge technology, a global video distribution network, and world-class instructors, INE Security is the top training choice for Fortune 500 companies worldwide for cybersecurity training in business and for IT professionals looking to advance their careers. INE Security's suite of learning paths offers an incomparable depth of expertise across cybersecurity and is committed to delivering advanced technical training while also lowering the barriers worldwide for those looking to enter and excel in an IT career. Kathryn Brown INE [email protected]

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store